Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Dementia

Trial Information

A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease

Official Title: A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease

Summary

The objective is to demonstrate that donepezil hydrochloride 10 mg/day has superior efficacy compared with placebo in cognitive function in Chinese subjects with severe Alzheimer's Disease.

Phase: Phase 3

Sponsor: Eisai Co., Ltd.

Overall Contacts:

Customer Joy Department. EJ

Locations (11)

Country State City Zip Facility and Contact
China Guangdong Guangzhou Research Site
China Hubei Wu Han Research Site
China Jiangsu Nanjing Research Site
China Shaanxi Xi'an Research Site
China Shandong Jinan Research Site
China Shandong Qingdao Research Site
China Sichuan Chengdu Research Site
China Zhejiang Hangzhou Research Site
China Beijing Research Site
China Chongqing Research Site
China Shanghai Research Site

NCT ID:NCT01404169

Date Last Changed: November 9, 2012